Global Hemostasis & Tissue Sealing Agents Market Size study, by Product (Topical Hemostat, Adhesive & Tissue Sealant) and Regional Forecasts 2022-2028

Global Hemostasis & Tissue Sealing Agents Market Size study, by Product (Topical Hemostat, Adhesive & Tissue Sealant) and Regional Forecasts 2022-2028

Global Hemostasis & Tissue Sealing Agents Market is valued approximately USD 6.13 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.80% over the forecast period 2022-2028. Hemostats and sealants are medical devices that are used to stop bleeding and hemorrhaging induced by injuries or surgical operations. The market is likely to grow profitably over the next seven years as demand rises, underpinned by increased surgery volumes. Growth in the senior population and the high prevalence of chronic illnesses are two important market factors. According to the Centers for Disease Control and Prevention (CDC), more than 45 percent of the American population has at least one chronic illness that necessitates critical care. Geriatric individuals require critical care and are more susceptible to injuries and wounds that take a long time to recover. With a growing demographic trend toward an active lifestyle, the number of everyday injuries and wounds is predicted to rise, driving market growth. The International Society for Thrombosis and Hemostasis published interim guidelines in March 2020 for the therapy and recognition of coagulopathy in COVID-19 patients based on the ISTH DIC score. Minimally invasive operations in the field of urology, in particular, are utilizing hemostatic treatments, supporting market growth. Cardiovascular problems have the most demand, followed by general procedures. Sealants and hemostats have a higher application in cardiovascular illnesses due to superior clinical results gained when compared to other wound closure procedures. The volume of surgical procedures is predicted to climb as the global frequency of chronic illnesses rises. This is projected to raise demand for wound healing and closure care even further. According to the CDC report of 2019, over 150 million Americans have at least one chronic illness that necessitates surgery. However, the lack of reimbursements for these items’ stifles market growth throughout the forecast period of 2022-2028.

The key regions considered for the Global Hemostasis & Tissue Sealing Agents Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America has emerged as the market leader because of the rising frequency of cardiovascular diseases, diabetes, and cancer in the region. Adhesives and sealants make for a sizable portion of the regional market in North America. Europe is predicted to have the second-largest market share in 2021 and the second-fastest CAGR over the forecast period. The introduction of cutting-edge and new products such as FLOSEAL, TISEEL, and HEMOPATCH is projected to drive demand from European countries.

Major market player included in this report are:
Johnson & Johnson
CryoLife, Inc.
Pfizer
C R Bard
B Braun
Covidien
Advance Medical Solutions Group
Smith & Nephew
Merk
Thermofisher Scientific
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Topical Hemostat
Adhesive & Tissue Sealant
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Hemostasis & Tissue Sealing Agents Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Johnson & Johnson
CryoLife, Inc.
Pfizer
C R Bard
B Braun
Covidien
Advance Medical Solutions Group
Smith & Nephew
Merk
Thermofisher Scientific

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.